Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AmerisourceBergen Corporation    ABC

AMERISOURCEBERGEN CORPORATION

(ABC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
05/27/2020 05/28/2020 05/29/2020 06/01/2020 06/02/2020 Date
93.33(c) 94.4(c) 95.34(c) 95.15(c) 98.66(c) Last
1 166 070 1 312 675 1 582 133 1 012 616 2 078 208 Volume
+2.81% +1.15% +1.00% -0.20% +3.69% Change
More quotes
Financials (USD)
Sales 2020 187 B - -
Net income 2020 1 802 M - -
Net Debt 2020 174 M - -
P/E ratio 2020 11,4x
Yield 2020 1,70%
Sales 2021 198 B - -
Net income 2021 1 486 M - -
Net cash position 2021 627 M - -
P/E ratio 2021 13,4x
Yield 2021 1,75%
Capitalization 20 068 M 20 068 M -
EV / Sales 2020 0,11x
EV / Sales 2021 0,10x
Nbr of Employees 21 500
Free-Float 51,0%
More Financials
Company
AmerisourceBergen Corporation specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services,... 
More about the company
Surperformance© ratings of AmerisourceBergen Corporat
Trading Rating : Investor Rating :
More Ratings
Latest news on AMERISOURCEBERGEN CORPORAT
05/26AMERISOURCEBERGEN : Selected by Deciphera Pharmaceuticals to Support QINLOCK&tra..
BU
05/19AMERISOURCEBERGEN CORP : Entry into a Material Definitive Agreement, Creation of..
AQ
05/19AMERISOURCEBERGEN : Closes $500 Million Senior Note Offering
BU
05/19AMERISOURCEBERGEN : DOJ Will Not Challenge COVID-19 Response Distribution Collab..
AQ
05/15AMERISOURCEBERGEN CORPORATION : Ex-dividend day for
FA
05/13AMERISOURCEBERGEN CORP : Regulation FD Disclosure, Other Events, Financial State..
AQ
05/12AMERISOURCEBERGEN : Prices $500 Million 2.800% Senior Notes Due 2030
BU
05/08AMERISOURCEBERGEN : Named a 2020 DiversityInc Noteworthy Company for Four Consec..
PU
05/07GILEAD SCIENCES : Health-Care Leaders Question How Remdesivir Is Being Distribut..
DJ
05/07GILEAD SCIENCES : Health-Care Leaders Question How Remedesivir Is Being Distribu..
DJ
05/07GILEAD SCIENCES : Health-Care Leaders Question How Remedesivir Is Being Distribu..
DJ
05/07Travel Sites Take a Hit from the Pandemic -- -2-
DJ
05/07Travel Sites Take a Hit from the Pandemic -- Earnings at a Glance
DJ
05/07AMERISOURCEBERGEN : Management's Discussion and Analysis of Financial Condition ..
AQ
05/07AMERISOURCEBERGEN CORP : Results of Operations and Financial Condition, Regulati..
AQ
More news
News in other languages on AMERISOURCEBERGEN CORPORAT
05/26AMERISOURCEBERGEN : Selected by Deciphera Pharmaceuticals to Support QINLOCK&tra..
05/19AMERISOURCEBERGEN CORP : Entry into a Material Definitive Agreement, Creation of..
05/19AMERISOURCEBERGEN : Closes $500 Million Senior Note Offering
05/19AMERISOURCEBERGEN : DOJ Will Not Challenge COVID-19 Response Distribution Collab..
05/15AMERISOURCEBERGEN CORPORATION : Ex-dividend day for
More news
Analyst Recommendations on AMERISOURCEBERGEN CORPORAT
More recommendations
Stock Trading Strategies
AMERISOURCEBERGEN CORPORATION - 05/11
The stock forcefully approaches new pivot levels
BUY
More Stock Trading Analysis
Chart AMERISOURCEBERGEN CORPORATION
Duration : Period :
AmerisourceBergen Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMERISOURCEBERGEN CORPORAT
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 101,33 $
Last Close Price 98,66 $
Spread / Highest target 21,6%
Spread / Average Target 2,71%
Spread / Lowest Target -13,8%
EPS Revisions
Managers
NameTitle
Steven H. Collis Chairman, President & Chief Executive Officer
James Francis Cleary Chief Financial Officer & Executive Vice President
Dale B. Danilewitz Chief Information Officer & Executive VP
Henry Wadsworth McGee Independent Director
Jane Ellen Henney Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
AMERISOURCEBERGEN CORPORATION11.91%20 068
MEDTRONIC PLC-14.28%130 232
BAXTER INTERNATIONAL INC.8.80%45 994
HOYA CORPORATION-2.73%35 708
DEXCOM, INC.71.78%34 971
TERUMO CORPORATION10.66%29 561